DarshanTalks Podcast

Fake data in Clinical Trials

10 Dec 2024

Contributed by Lukas

Florida medical clinic owner and staff were charged with falsifying clinical trial data. According to the indictment, from September 2015 to March 201...

Darshan Fixes Big Pharma Misconceptions

08 Dec 2024

Contributed by Lukas

In this reaction video, Darshan responds to claims about the effectiveness of prescribed medications. While patients often expect their drugs to work,...

How Trump’s Tariffs will Disrupt Clinical Trials and Drug Marketing?

06 Dec 2024

Contributed by Lukas

In today's podcast, we dive into President Trump's proposed tariffs on Canada, Mexico, and China and what these moves could mean for the lif...

Why China is Targeting Top Scientists!

04 Dec 2024

Contributed by Lukas

The Wall Street Journal recently reported that China is aggressively targeting tech talent with lucrative job offers, offering triple the pay for posi...

Trump’s Bold Picks Shake Up Life Sciences

02 Dec 2024

Contributed by Lukas

The Trump administration’s new appointees, including Elon Musk, Dr. Marty Makary, Dr. Jay Bhattacharya, and Robert F. Kennedy Jr., promise a signifi...

3 Regulatory Opportunities in Clinical Trials!

30 Nov 2024

Contributed by Lukas

We explore the rapidly evolving role of artificial intelligence (AI) in clinical trial research design. He discusses how AI is reshaping the pharmaceu...

Don't Take Non-Prescription Ozempic or other Weight Loss Drugs

28 Nov 2024

Contributed by Lukas

We explore the emerging trend of patients bypassing traditional healthcare to obtain weight loss medications like Ozempic through unofficial channels ...

Clinical Trial Principal Investigator Duties in Clinical Trials

26 Nov 2024

Contributed by Lukas

The FDA has stressed the critical importance of adequate supervision and monitoring in clinical trials to ensure they are conducted properly. A key fi...

Supreme Court Redefined Pharma Marketing Rules

23 Nov 2024

Contributed by Lukas

The Supreme Court's ruling in Loper Bright Enterprises v. Raimondo significantly impacts off-label marketing for pharmaceutical and medical devic...

AI concerns in M&A for Life Sciences

20 Nov 2024

Contributed by Lukas

Artificial intelligence (AI) is transforming the life sciences sector, offering groundbreaking advancements in areas like drug discovery, clinical tri...

Trump Teams Potential Changes to Healthcare

19 Nov 2024

Contributed by Lukas

Healthcare and life sciences are on the brink of transformative change, fueled by a combination of technological innovation, ideological shifts, and e...

Can AI Rewrite the Rules of Clinical Trials?

18 Nov 2024

Contributed by Lukas

In this episode, we're diving into the intersection of technology and healthcare, specifically the role of Artificial Intelligence (AI) in clinic...

Ad Promo Review in Pharma - How Far is Too Far?

16 Nov 2024

Contributed by Lukas

Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance i...

Why Staff Training Problems are a liability for Your Clinical Trial site

14 Nov 2024

Contributed by Lukas

Training your research site staff is critical. Despite regulations requiring Principal Investigators (PIs) to ensure proper training for research staf...

Neuralink: Breakthrough or Marketing Hype?

12 Nov 2024

Contributed by Lukas

Neuralink recently received the FDA's Breakthrough Device label for its neural implant aimed at restoring vision to the blind by interfacing with...

Telehealth Compliance Crisis: DOJ exposes $2.75B Fraud!

09 Nov 2024

Contributed by Lukas

DOJ filed criminal charges against 193 defendants, including 76 medical professionals for telemedicine violation. This alarming crackdown reveals the ...

Should You Go In-House or Outsource Your Advertising Compliance?

06 Nov 2024

Contributed by Lukas

In this episode, Heather McFalls discusses the pros and cons of in-house versus outsourced advertising compliance roles, along with tips for new regul...

Research fraud tainting pharma per Nature Article

04 Nov 2024

Contributed by Lukas

Nature and Vox highlight the severe consequences of research fraud and its widespread impact on sectors like marketing, clinical research, medical aff...

Influencers are NOT KOLs. Know your Needs!

31 Oct 2024

Contributed by Lukas

Influencers are NOT KOLs. We discuss using key opinion leaders (KOLs) and influencers in pharmaceutical and medical device marketing. Key Takeaways:-...

AI and Clinical Trials: Faster Results, Bigger Risks?

28 Oct 2024

Contributed by Lukas

In this episode, we’re diving into a crucial topic: the role of artificial intelligence in clinical research and the evolving landscape of data priv...

Eli Lilly’s Unexpected Shift on Use of Mounjaro!

25 Oct 2024

Contributed by Lukas

Eli Lilly's changed its opinion on Off-Label uses! Eli Lilly, a company that makes a diabetes drug, is now urging people not to use it for weight...

Are CROs Losing Relevance in the Age of DCTs?

23 Oct 2024

Contributed by Lukas

In this episode, Isaac Rodriguez- Chavez and I discuss the impact of DCTs on sponsor relationships, CROs, and industry dynamics with the FDA. We disc...

Managing Risks in Life Science Mergers and Acquisitions with Strategic Insurance

19 Oct 2024

Contributed by Lukas

In this episode, we discuss the importance of integrating insurance considerations into the due diligence process during M&A transactions with Ken...

Can a Pharmacist Override Your Doctor's Prescription?

17 Oct 2024

Contributed by Lukas

We'll briefly discuss when a pharmacist might choose not to dispense medication, even with a valid doctor's order.In a recent case, a doctor...

FDA Concerns About AI’s impact on Good Clinical Practices

15 Oct 2024

Contributed by Lukas

Today we're delving into the evolving role of artificial intelligence (AI) in drug development and clinical trial design. We’ll explore the key...

Patient Advocates Could Cost You Millions

11 Oct 2024

Contributed by Lukas

Patient Advocates play a crucial role in the pharmaceutical industry, especially in clinical research. They serve as the voice of patients, ensuring t...

Managing Risks in Life Sciences Mergers and Acquisitions

08 Oct 2024

Contributed by Lukas

In this episode, we discuss key risks a life sciences company should consider during an acquisition with Kenneth White. We also explore the role of in...

How do pharmacists’ read doctors’ cursive letters?

06 Oct 2024

Contributed by Lukas

Pharmacists often use a process of elimination to decipher doctors' handwritten prescriptions. Pharmacists rely on clues like drug names and dose...

AI Data Ownership in Pharma

03 Oct 2024

Contributed by Lukas

We explore how AI is transforming content generation in the pharmaceutical industry, particularly in marketing, sales, and medical engagements. While ...

Role of Tech Transfer in Clinical trial agreements

30 Sep 2024

Contributed by Lukas

In this episode, we are joined by Istvan Fekete to have a discussion over tech transfer offices, IP, and more. The video explains what tech transfer o...

Why are medicine names so complicated?

22 Sep 2024

Contributed by Lukas

Darshan was asked to explain why drug names can be so complicated, and the answer lies in the fact that each drug typically has at least three distinc...

Fixing Congruency Reviews in 8 Minutes

21 Sep 2024

Contributed by Lukas

In this episode, Istvan Fekete joins us to discuss the intricacies of Congruency Reviews. We will explore the common mistakes individuals may encounte...

The Dark Side of Med Device Kickbacks

17 Sep 2024

Contributed by Lukas

Today, we're discussing a critical issue for pharmaceutical and medical device marketers – promotional compliance.Overview of the Innovasis Set...

Which Hair Loss Treatment Is Right for You?

14 Sep 2024

Contributed by Lukas

Darshan addresses common questions about potential treatments for hair loss. He provides insights based on his expertise as both a pharmacist and an F...

Analyzing the Publication Rights Clause in CTAs

09 Sep 2024

Contributed by Lukas

Today's discussion revolves around the legal clauses found in clinical trials, with a focus on Article 8, the Publication Rights Clause.The foll...

What Really Starts Pharmacy Investigations?

07 Sep 2024

Contributed by Lukas

We discuss the seven ways pharmacy investigations can begin:1. Data Analysis: Agencies like the DEA and DOJ monitor prescription data for unusual patt...

Is your clinical trial AI racist?

20 Aug 2024

Contributed by Lukas

We dive into the critical issue of racial bias in AI, highlighted by a recent Yale study focusing on ChatGPT. This has significant implications for cl...

Another Pharmacy owner Jailed in Fraud Case

17 Aug 2024

Contributed by Lukas

Today we're diving into a critical issue that has shaken the pharmacy world. Recently, a pharmacy owner was sentenced for paying illegal kickback...

Navigating FDA's clinical trial expectations after approval

13 Aug 2024

Contributed by Lukas

Today, we're diving into the FDA's Fiscal Year 2022 report on postmarketing requirements (PMRs) and postmarketing commitments (PMCs). PMRs ...

Legal Minute: Do dietary supplements interact with drugs?

09 Aug 2024

Contributed by Lukas

Do dietary supplements interact with drugs? Many people think only prescription drugs can cause interactions, but dietary supplements can too. From an...

How Expert Pharma Marketers Navigate Privacy

07 Aug 2024

Contributed by Lukas

In today's consumer landscape, privacy concerns reign supreme. Pharmaceutical and medical device manufacturers must prioritize meeting the expect...

Hiring New Employees in PharmaTech Companies

02 Aug 2024

Contributed by Lukas

Edye Edens, a consultant and attorney with a background in regulatory affairs, shared insights into her unexpected yet exciting role at Weave, a rapid...

3 Hidden Dangers of Telehealth Marketing

29 Jul 2024

Contributed by Lukas

 In this episode, we discuss how drug and device manufacturers may seem to collaborate with telemedicine companies to market products and ensure pati...

Why a food lawyer would stop your restaurant’s marketing?

26 Jul 2024

Contributed by Lukas

Today, we're tackling a critical issue for restaurants and food marketers: promotional compliance and the risks of misbranding, as highlighted by...

Legal Minute: Why are there chemo drug shortages?

24 Jul 2024

Contributed by Lukas

We discuss how the shortage of chemotherapy drugs stems from economic challenges faced by generic drug manufacturers. Many cannot afford to produce th...

Are Pharma Giants Ignoring Clinical Trial Site Issues?

22 Jul 2024

Contributed by Lukas

In this episode, Daniel Fox discusses the key challenges faced by research sites, including trust issues, payment delays, and operational setbacks. He...

Why Adverse Events Go Unreported in Clinical Trials

18 Jul 2024

Contributed by Lukas

In clinical trials, reporting adverse events and protocol deviations is crucial for patient safety and trial integrity. However, some sites may hesita...

Who are patient advocates?

16 Jul 2024

Contributed by Lukas

In this episode, we delved into the pivotal role of patient advocates within the pharmaceutical industry. Patient advocates are champions who ensure t...

Why Drug Accountability Matters in Clinical Trials

11 Jul 2024

Contributed by Lukas

Drug accountability is a critical aspect monitored by the FDA at clinical trial sites. Principal investigators must maintain and document control over...

Legal Minute: What do I do if my med is on shortage?

09 Jul 2024

Contributed by Lukas

We discuss how to address drug shortages. First things first, it's important to stay calm. Just because there's a shortage doesn't mean...

5 reasons not to use AI in creating pharma marketing content

07 Jul 2024

Contributed by Lukas

We discuss the risks associated with using AI in your pharma marketing plans: 1.     Data Privacy and Security: Ensuring the security and privacy ...

8 essential elements of a valid prescription

06 Jul 2024

Contributed by Lukas

In this episode, we discussed eight essential strategies to prevent prescription drug fraud and abuse:Verify the prescriber's identity.Know the p...

No more lawyers in PRC?

04 Jul 2024

Contributed by Lukas

In this episode we're joined by Heather McFalls, Director of Promotion Compliance at Otsuka Pharmaceutical Companies to discuss the evolving role...

Legal Minute: 4 Ways to Get Unapproved Drugs Legally!

02 Jul 2024

Contributed by Lukas

Today, we discuss four legal pathways to acquire unapproved drugs. First, over-the-counter drugs offer a route as some bypass FDA approvals, relying ...

The 4 Building Blocks of Using AI in any Pharma Marketing Strategy

27 Jun 2024

Contributed by Lukas

We discuss the essential elements to ensure that your pharma marketing plan aligns with AI use:1. Define Clear Goals: Establishing clear objectives is...

Legal Minute: Why Clinical Trials Are Right for You!

26 Jun 2024

Contributed by Lukas

In this short, we explore four key reasons to get involved in clinical research.First, it offers potential access to cutting-edge therapies, though it...

Why Clinical Researchers Are Flocking to MedSpas

24 Jun 2024

Contributed by Lukas

In today’s episode, our guest is Andrew Stein, a partner in the healthcare department at Stevens and Lee .Darshan and Andrew discuss MedSpas. MedSpa...

Legal Minute: Why You Should Never Trust a Celebrity with Your Health

18 Jun 2024

Contributed by Lukas

Darshan explains  why you shouldn’t Trust Celebrities When Choosing Your Drugs!Hidden Agendas: They're paid to promote, not give unbiased advi...

Essential tips for pharmacy shutdowns

16 Jun 2024

Contributed by Lukas

Recent pharmacy walkouts and closures at major chains highlight a critical issue: staffing shortages. Independent pharmacies are also at risk. Here a...

Why Clinical Researchers Are Flocking to MedSpas

14 Jun 2024

Contributed by Lukas

In today’s episode, our guest is Andrew Stein, a partner in the healthcare department at Stevens and Lee.Darshan and Andrew discuss MedSpas. MedSpas...

Legal Minute: 5 Surprising Benefits of Ozempic!

11 Jun 2024

Contributed by Lukas

We dive deep into 5 uses of  Ozempic, a drug known for managing diabetes, but with surprising potential beyond! Here are 5 intriguing uses you might ...

Who Owns AI Generated Content in Pharma?

08 Jun 2024

Contributed by Lukas

In today's episode, we discuss AI-generated content in the pharmaceutical industry. AI has revolutionized content creation, but it's not wit...

Legal Minute: Why does my drug cost so much?

07 Jun 2024

Contributed by Lukas

In today’s short, Darshan discusses why drugs cost so much. It takes around 10 to 15 years and roughly $2.3 billion to bring a drug to market. That ...

AI for Promotions in FDA-Regulated Industries

06 Jun 2024

Contributed by Lukas

Join Darshan Kulkarni, a Food and Drug attorney, as he explores the dynamic intersection of artificial intelligence, drug and device promotion, and th...

Legal Minute: Billion-Dollar Speaker Scheme!

05 Jun 2024

Contributed by Lukas

Speaker programs are events sponsored by drug and device companies where a physician or other healthcare professional (HCP) delivers a speech or prese...

Off-Label Risks: Compliance Matters Now More Than Ever

03 Jun 2024

Contributed by Lukas

We shed light on the complexities surrounding off-label promotion and reimbursement in the pharmaceutical industry.We discuss the following:What does ...

6 Must-Knows Before Buying a Drug or Device Company

30 May 2024

Contributed by Lukas

Buying a Drug or Device Company? 6 Compliance Must-KnowsThinking of acquiring a drug or device company? Buckle up! This deal requires serious complian...

Legal Minute: Are there chemo drug shortages?

28 May 2024

Contributed by Lukas

We discuss how recent shortages of chemotherapy drugs like cisplatin and carboplatin have caused delays and changes in treatment plans for some cancer...

Legal Minute: Don’t Ignore State Registrations

24 May 2024

Contributed by Lukas

We discuss how failure to register with the appropriate state boards of Pharmacy as a drug or device manufacturer can lead to severe consequences. The...

Legal Minute: 6 Crucial Mistakes in Informed Consent

20 May 2024

Contributed by Lukas

We discuss six critical errors in the informed consent process:1. Exclusion of Principal Investigator: PI was not allowed to engage in the informed co...

Legal Minute: What is informed consent in clinical trials?

16 May 2024

Contributed by Lukas

Informed consent is a crucial aspect of clinical trials, ensuring that prospective subjects understand the benefits, risks, and potential harms of par...

Stop Risky Ads: Class Actions Could Cost You

13 May 2024

Contributed by Lukas

In this podcast, we discuss the following: Recent updates from the courts in class action lawsuits. Difference between equity and law. Demerging or...

Legal Minute: How do drugs work?

08 May 2024

Contributed by Lukas

Darshan explains that drugs work by either enhancing or inhibiting processes that already occur in the body. Put simply, they amplify or reduce the bo...

5 Surprising Causes of Life Science Deal Failures

03 May 2024

Contributed by Lukas

We discuss the five common reasons behind the failure of mergers, acquisitions and licensing deals  in the life sciences industry. Inadequate unders...

Legal Minute: Is pharma bribing your doctor?

29 Apr 2024

Contributed by Lukas

In this short, Darshan sheds light on the relationship between doctors and pharmaceutical companies. He explains how pharmaceutical companies often pa...

Legal Minute: Drug Registrations that can’t be ignored

23 Apr 2024

Contributed by Lukas

When acquiring a drug or device company, regulatory attorneys play a crucial role in ensuring compliance during the due diligence process. It's v...

Legal Minute: Why do pharmacies take so long to fill prescriptions?

19 Apr 2024

Contributed by Lukas

Have you ever wondered why your prescription takes what feels like an eternity to fill at the pharmacy? Darshan will shed some light on the process. ...

Legal Minute: 3 Steps to Avoid Food Recalls

15 Apr 2024

Contributed by Lukas

We cover three steps for preventing food recalls:Identify all potential hazards.Focus on known and foreseeable risks.Develop preventive controls for s...

Legal Minute: Are dietary supplements as good as drugs?

12 Apr 2024

Contributed by Lukas

In this video, Darshan distinguishes between dietary supplements and drugs. The primary difference lies in the claims they can make. Dietary suppleme...

Legal Minute: Clinical Trial Record Retention Disasters

08 Apr 2024

Contributed by Lukas

Here are 5 clinical trial record retention problems.1. Fabricating Data and Documentation,2. Forging the Principal Investigator's signatures,3. D...

Legal Minute: Why is your medicine so expensive?

04 Apr 2024

Contributed by Lukas

Bringing a drug to market is a costly and intricate process, averaging $2.3 billion. This expense encompasses multiple levels of testing, ranging from...

McKinsey’s 2030 vision: A challenge for medical affairs

01 Apr 2024

Contributed by Lukas

McKinsey’s vision for Medical Affairs in 2030 envisions profound integration of digital tools, analytical innovation, evidence generation, and leade...

Legal Minute: 3 must-do takeaways for collecting diversity data in clinical trials

29 Mar 2024

Contributed by Lukas

In an ideal world, every patient in clinical trials would feel truly represented. In this video, Darshan Kulkarni outlines three crucial takeaways for...

Legal Minute: Are Brand and Generic Drugs Truly Different?

23 Mar 2024

Contributed by Lukas

We explore the chemical similarities and key differences between brand-name and generic drugs. Learn about:Equivalence in active ingredients, as appro...

Legal Minute: Who's REALLY Responsible for a Clinical Trial Congruency review?

18 Mar 2024

Contributed by Lukas

In this short, we discuss who is responsible for a congruency review in clinical trials. Our guest Istvan Fekete emphasizes that both pharmaceutical c...

This Drug Ad is FULL of Red Flags (We Expose Them All!)

13 Mar 2024

Contributed by Lukas

Today, we analyze a fictional drug advertisement, identifying and highlighting the nine key unethical and non-compliant elements.- Misleading Informat...

7 ways to challenge FDA’s regulation of LDTs

09 Mar 2024

Contributed by Lukas

The FDA's announcement of its intention to regulate Lab Developed Tests (LDTs) in line with medical device regulations has sparked concerns among...

Legal Minute: eBay’s $59 Million Drug-Making Problem

06 Mar 2024

Contributed by Lukas

eBay found itself as an unexpected marketplace for pill-making equipment, resulting in the company paying a hefty $59 million for facilitating the sal...

Legal Minute: Neuralink is a Game-Changer: 3 Lessons You Can't Afford to Miss

02 Mar 2024

Contributed by Lukas

In a recent announcement, Elon Musk's company Neuralink revealed the successful implantation of a brain device in a human, pushing the boundaries...

Legal Minute: Off-label marketing not ok again?

27 Feb 2024

Contributed by Lukas

In the US v. Facteau case, a recent development adds complexity to the FDA's ongoing struggle with off-label communications, particularly in ligh...

Don't Become the Next Fraud Headline: Lawyer Reveals Compliance Traps

25 Feb 2024

Contributed by Lukas

We discuss biotech fraud and the pivotal role of a comprehensive legal strategy, especially one that integrates FDA regulatory lawyers. A biotech CEO&...

Legal Minute: 3 Insider Secrets for a Successful Medical Device Recall

19 Feb 2024

Contributed by Lukas

In December 2023, two US senators raised concerns, urging the government to scrutinize the FDA's oversight of medical device recalls, notably ami...

Key elements of a successful congruency review for clinical trial agreements

15 Feb 2024

Contributed by Lukas

In a congruency review, the primary objective is to ensure alignment across various elements in clinical research. The initial crucial step involves a...

Why Private Equity firms are betting big on clinical research sites

12 Feb 2024

Contributed by Lukas

We delve into the growing allure of clinical research sites and organizations for private equity firms. Backed by BPOC, these investments signify more...

5 Ways to Legally Share Off-Label Information

07 Feb 2024

Contributed by Lukas

In this episode, the focus is on navigating the complex landscape of off-label information sharing, exploring legal aspects in the context of the life...

DOJ's "Get Out of Jail Free" card for pharma and device mergers?

04 Feb 2024

Contributed by Lukas

Darshan discussed crucial updates to the Department of Justice's (DOJ) corporate enforcement policies, particularly impacting FDA-regulated indus...

Legal Minute: 5 factors to get your digital speaker program approved

01 Feb 2024

Contributed by Lukas

In this podcast, we discuss the legal and regulatory factors for securing approval for your digital speaker program. Key points include prioritizing ...

Legal Minute: Decoding the FDA's prescription drug use related software guidance

30 Jan 2024

Contributed by Lukas

FDA Issues Crucial Guidance on Prescription Drug Software! Darshan Kulkarni delves into the FDA's recent guidance on prescription drug-related s...

Congruency Review: The Game Changer

28 Jan 2024

Contributed by Lukas

Insider Exposes crucial missing step in Clinical Trial Agreements activation - Congruency Review Details Revealed!In the clinical trial agreement acti...

Legal Minute: 5 hacks to fast-track your speaker program reviews

24 Jan 2024

Contributed by Lukas

Accelerate your digital speaker program review with these 5 game-changing strategies: Policy Creation & Training Pre-reviews AI-based Reviews ...